Casein peptone sales will expand through 2036, with enzymatic hydrolyzed casein peptone holding 54.6% of the product type segment in 2026. The market was valued at USD 429.5 million in 2025 and is expected to be worth USD 640.5 million by 2036, creating an incremental opportunity of USD 195.1 million.